title: Oral antidiabetic agents safe with renal disease?
authors.affiliation: Department of Preventive Medicine, Rush-Presbyterian-St Luke's Medical Center, Chicago, USA.
authors.forename: G
authors.initials: G
authors.lastname: Bakris
mesh_terms: D000368:Aged; D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000150:complications; D008687:Metformin / Q000008:administration & dosage; D000077154:Rosiglitazone; D013844:Thiazoles / Q000008:administration & dosage; D045162:Thiazolidinediones
chemical_list: D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D008687:Metformin